Literature DB >> 26546047

Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer.

Alyssa L Smith1, Najmeh Alirezaie2, Ashton Connor3, Michelle Chan-Seng-Yue4, Robert Grant5, Iris Selander5, Claire Bascuñana1, Ayelet Borgida6, Anita Hall1, Thomas Whelan5, Spring Holter6, Treasa McPherson5, Sean Cleary6, Gloria M Petersen7, Atilla Omeroglu8, Emmanouil Saloustros9, John McPherson4, Lincoln D Stein4, William D Foulkes10, Jacek Majewski2, Steven Gallinger11, George Zogopoulos12.   

Abstract

The genetic basis underlying the majority of hereditary pancreatic adenocarcinoma (PC) is unknown. Since DNA repair genes are widely implicated in gastrointestinal malignancies, including PC, we hypothesized that there are novel DNA repair PC susceptibility genes. As germline DNA repair gene mutations may lead to PC subtypes with selective therapeutic responses, we also hypothesized that there is an overall survival (OS) difference in mutation carriers versus non-carriers. We therefore interrogated the germline exomes of 109 high-risk PC cases for rare protein-truncating variants (PTVs) in 513 putative DNA repair genes. We identified PTVs in 41 novel genes among 36 kindred. Additional genetic evidence for causality was obtained for 17 genes, with FAN1, NEK1 and RHNO1 emerging as the strongest candidates. An OS difference was observed for carriers versus non-carriers of PTVs with early stage (≤IIB) disease. This adverse survival trend in carriers with early stage disease was also observed in an independent series of 130 PC cases. We identified candidate DNA repair PC susceptibility genes and suggest that carriers of a germline PTV in a DNA repair gene with early stage disease have worse survival.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  DNA repair genes; Exome sequencing; Familial pancreatic cancer; Pancreatic adenocarcinoma

Mesh:

Substances:

Year:  2015        PMID: 26546047      PMCID: PMC5725760          DOI: 10.1016/j.canlet.2015.10.030

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  50 in total

1.  Fanconi anemia gene mutations in young-onset pancreatic cancer.

Authors:  Michiel S van der Heijden; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

2.  The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes.

Authors:  Kim D Pruitt; Jennifer Harrow; Rachel A Harte; Craig Wallin; Mark Diekhans; Donna R Maglott; Steve Searle; Catherine M Farrell; Jane E Loveland; Barbara J Ruef; Elizabeth Hart; Marie-Marthe Suner; Melissa J Landrum; Bronwen Aken; Sarah Ayling; Robert Baertsch; Julio Fernandez-Banet; Joshua L Cherry; Val Curwen; Michael Dicuccio; Manolis Kellis; Jennifer Lee; Michael F Lin; Michael Schuster; Andrew Shkeda; Clara Amid; Garth Brown; Oksana Dukhanina; Adam Frankish; Jennifer Hart; Bonnie L Maidak; Jonathan Mudge; Michael R Murphy; Terence Murphy; Jeena Rajan; Bhanu Rajput; Lillian D Riddick; Catherine Snow; Charles Steward; David Webb; Janet A Weber; Laurens Wilming; Wenyu Wu; Ewan Birney; David Haussler; Tim Hubbard; James Ostell; Richard Durbin; David Lipman
Journal:  Genome Res       Date:  2009-06-04       Impact factor: 9.043

3.  A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling.

Authors:  Cecilia Cotta-Ramusino; E Robert McDonald; Kristen Hurov; Mathew E Sowa; J Wade Harper; Stephen J Elledge
Journal:  Science       Date:  2011-06-10       Impact factor: 47.728

4.  Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673.

Authors:  Alexandra-Zoe Andrei; Anita Hall; Alyssa L Smith; Claire Bascuñana; Abba Malina; Ashton Connor; Gulbeyaz Altinel-Omeroglu; Sidong Huang; Jerry Pelletier; David Huntsman; Steven Gallinger; Atilla Omeroglu; Peter Metrakos; George Zogopoulos
Journal:  Cancer Lett       Date:  2015-04-09       Impact factor: 8.679

5.  Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.

Authors:  Nuria Seguí; Leonardo B Mina; Conxi Lázaro; Rebeca Sanz-Pamplona; Tirso Pons; Matilde Navarro; Fernando Bellido; Adriana López-Doriga; Rafael Valdés-Mas; Marta Pineda; Elisabet Guinó; August Vidal; José Luís Soto; Trinidad Caldés; Mercedes Durán; Miguel Urioste; Daniel Rueda; Joan Brunet; Milagros Balbín; Pilar Blay; Silvia Iglesias; Pilar Garré; Enrique Lastra; Ana Beatriz Sánchez-Heras; Alfonso Valencia; Victor Moreno; Miguel Ángel Pujana; Alberto Villanueva; Ignacio Blanco; Gabriel Capellá; Jordi Surrallés; Xose S Puente; Laura Valle
Journal:  Gastroenterology       Date:  2015-06-05       Impact factor: 22.682

6.  Double heterozygotes among breast cancer patients analyzed for BRCA1, CHEK2, ATM, NBN/NBS1, and BLM germ-line mutations.

Authors:  Anna P Sokolenko; Natalia Bogdanova; Wojciech Kluzniak; Elena V Preobrazhenskaya; Ekatherina S Kuligina; Aglaya G Iyevleva; Svetlana N Aleksakhina; Natalia V Mitiushkina; Tatiana V Gorodnova; Alexandr A Bessonov; Alexandr V Togo; Jan Lubiński; Cezary Cybulski; Anna Jakubowska; Thilo Dörk; Evgeny N Imyanitov
Journal:  Breast Cancer Res Treat       Date:  2014-05-07       Impact factor: 4.872

Review 7.  Managing hereditary gastrointestinal cancer syndromes: the partnership between genetic counselors and gastroenterologists.

Authors:  Wendy S Rubinstein; Scott M Weissman
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-09-16

8.  Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer.

Authors:  P Langer; P H Kann; V Fendrich; N Habbe; M Schneider; M Sina; E P Slater; J T Heverhagen; T M Gress; M Rothmund; D K Bartsch
Journal:  Gut       Date:  2009-05-25       Impact factor: 23.059

9.  Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer.

Authors:  Robert C Grant; Wigdan Al-Sukhni; Ayelet E Borgida; Spring Holter; Zaheer S Kanji; Treasa McPherson; Emily Whelan; Stefano Serra; Quang M Trinh; Vanya Peltekova; Lincoln D Stein; John D McPherson; Steven Gallinger
Journal:  Hum Genomics       Date:  2013-04-05       Impact factor: 4.639

10.  ClinVar: public archive of relationships among sequence variation and human phenotype.

Authors:  Melissa J Landrum; Jennifer M Lee; George R Riley; Wonhee Jang; Wendy S Rubinstein; Deanna M Church; Donna R Maglott
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  23 in total

Review 1.  Familial pancreatic cancer.

Authors:  Gloria M Petersen
Journal:  Semin Oncol       Date:  2016-09-22       Impact factor: 4.929

2.  Structural mechanism of DNA interstrand cross-link unhooking by the bacterial FAN1 nuclease.

Authors:  Hyeonseok Jin; Upasana Roy; Gwangrog Lee; Orlando D Schärer; Yunje Cho
Journal:  J Biol Chem       Date:  2018-03-07       Impact factor: 5.157

Review 3.  Progress report: familial pancreatic cancer.

Authors:  Ioannis Mintziras; Detlef K Bartsch
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

4.  The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.

Authors:  Thomas P Slavin; Susan L Neuhausen; Bita Nehoray; Mariana Niell-Swiller; Ilana Solomon; Christina Rybak; Kathleen Blazer; Aaron Adamson; Kai Yang; Sharon Sand; Nancy Guerrero-Llamas; Danielle Castillo; Josef Herzog; Xiwei Wu; Shu Tao; Shivali Raja; Vincent Chung; Gagandeep Singh; Sue Nadesan; Sandra Brown; Marcia Cruz-Correa; Gloria M Petersen; Jeffrey Weitzel
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

Review 5.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

6.  Exome-Wide Association Study of Pancreatic Cancer Risk.

Authors:  Robert C Grant; Robert E Denroche; Ayelet Borgida; Carl Virtanen; Natalie Cook; Alyssa L Smith; Ashton A Connor; Julie M Wilson; Gloria Peterson; Nicholas J Roberts; Alison P Klein; Sean M Grimmond; Andrew Biankin; Sean Cleary; Malcolm Moore; Mathieu Lemire; George Zogopoulos; Lincoln Stein; Steven Gallinger
Journal:  Gastroenterology       Date:  2017-10-24       Impact factor: 22.682

Review 7.  The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.

Authors:  Elizabeth D Thompson; Nicholas J Roberts; Laura D Wood; James R Eshleman; Michael G Goggins; Scott E Kern; Alison P Klein; Ralph H Hruban
Journal:  Mod Pathol       Date:  2020-07-23       Impact factor: 7.842

8.  Fan1 deficiency results in DNA interstrand cross-link repair defects, enhanced tissue karyomegaly, and organ dysfunction.

Authors:  Supawat Thongthip; Marina Bellani; Siobhan Q Gregg; Sunandini Sridhar; Brooke A Conti; Yanglu Chen; Michael M Seidman; Agata Smogorzewska
Journal:  Genes Dev       Date:  2016-03-15       Impact factor: 11.361

9.  The lipogenic LXR-SREBF1 signaling pathway controls cancer cell DNA repair and apoptosis and is a vulnerable point of malignant tumors for cancer therapy.

Authors:  Bo Yang; Bin Zhang; Zhifei Cao; Xingdong Xu; Zihe Huo; Pan Zhang; Shufen Xiang; Zhe Zhao; Chunping Lv; Mei Meng; Gaochuan Zhang; Liang Dong; Shucheng Shi; Lan Yang; Quansheng Zhou
Journal:  Cell Death Differ       Date:  2020-03-06       Impact factor: 15.828

10.  Ubiquitinated Fancd2 recruits Fan1 to stalled replication forks to prevent genome instability.

Authors:  Christophe Lachaud; Alberto Moreno; Francesco Marchesi; Rachel Toth; J Julian Blow; John Rouse
Journal:  Science       Date:  2016-01-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.